How to read: Every bubble is one Indian cyclosporine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Cyclosporine report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial cyclosporine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian cyclosporine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Cyclosporine India trade report
P
Product scope
Cyclosporine
All variants merged — branded and generic formulations of cyclosporine
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
212
Every commercial cyclosporine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $5.5K, Nov $810.2K, Dec $275.3K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$5.5K
Oct USD
15 shipments
2
$810.2K
Nov USD
+14561.1% MoM
3
$275.3K
Dec USD
-66.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 14561.1% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $6K, making it the weakest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: PANACEA BIOTEC PHARMA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import cyclosporine from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 61.9% of India’s 2025-Q4 cyclosporine trade ($675.7K). Beyond the top 10 destinations, 31 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 31 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much cyclosporine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$142K
13.0% of trade
12 countries · 128 shipments
Europe
$434
0.0% of trade
1 countries · 2 shipments
Americas
$786K
72.0% of trade
7 countries · 15 shipments
Africa
$162K
14.9% of trade
11 countries · 64 shipments
Oceania
$39
0.0% of trade
1 countries · 3 shipments
Fig 4.1 United States is the #1 corridor ($676K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian cyclosporine it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$676K
4
ONESOURCE SPECIALTY PHARMA LTD
$676K
—
—
—
—
2
Angola
$100K
2
INVEX HEALTH PVT LTD
$100K
—
—
—
—
3
Ecuador
$67K
2
PANACEA BIOTEC PHARMA LTD
$63K
HIRAL LABS LTD
$5K
—
—
4
Myanmar
$50K
3
RPG LIFE SCIENCES LTD
$29K
PANACEA BIOTEC PHARMA LTD
$22K
—
—
5
Qatar
$42K
2
RIZOCHEM PHARMACEUTICALS
$42K
—
—
—
—
6
Venezuela
$42K
3
AMRS HEALTHCARE PVT LTD
$42K
—
—
—
—
7
Egypt
$41K
3
RPG LIFE SCIENCES LTD
$41K
—
—
—
—
8
Philippines
$26K
2
RPG LIFE SCIENCES LTD
$26K
—
—
—
—
9
United Arab Emirates
$11K
92
DERRIC WOOD
$5K
GAIA TRADE PVT LTD
$3K
LAWRENCE WALTER
$1K
10
Mauritius
$8K
12
PLEASANT EXPORTS
$6K
SAVA HEALTHCARE LTD
$2K
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 13.0% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
61.9%
#1 country share
United States alone
85.8%
Top 5 share
5 of 32 countries
99.3%
Top 15 share
Long tail of 17 countries = 0.7%
HHI 4031
Destination HHI
Highly concentrated
32
Countries served
Global pharma reach from India
12
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
41 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYONESOURCE SPECIALTY PHARMA LTD ($675.7K, 61.9% share) and INVEX HEALTH PVT LTD ($99.8K) together control 71.1% of India’s 2025-Q4 cyclosporine trade. The top 5 suppliers hold 91.4%. 41 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian cyclosporine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ONESOURCE SPECIALTY PHARMA LTD leads by $576K over INVEX HEALTH PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: LAWRENCE WALTER is #18 by value but #2 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (48) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: LAWRENCE WALTER moves from #2 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 41 cyclosporine suppliers split into strategic segments
KEY TAKEAWAY11 suppliers (25%) generate 97.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ONESOURCE SPECIALTY PHARMA LTD and INVEX HEALTH PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.8% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
30 importers across 32 countries — who is buying Indian cyclosporine and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 90.8% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian cyclosporine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 AVET PHARMACEUTICALS INC is the #1 importer at $676K (61.9%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian cyclosporine prices vary by supplier, country and dosage form
KEY TAKEAWAYCyclosporine prices span 1932× ($0.022 → $43.41). The coefficient of variation is 1.38. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. AMRS HEALTHCARE PVTSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ONESOURCE SPECIALTY PHARMASourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. INVEX HEALTH PVTSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. RIZOCHEM PHARMACEUTICALSSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
RPG LIFE SCIENCE…
Philippines
Capsule
200
$13K
$64.70
Specialty / small-batch
Dec 2025
RPG LIFE SCIENCE…
Philippines
Capsule
200
$13K
$62.80
Specialty / small-batch
Oct 2025
PLEASANT EXPORTS
Sri Lanka
Solution
10
$434.06
$43.41
Specialty / small-batch
Dec 2025
SPECIALITY MEDIC…
Lithuania
Solution
10
$415.77
$41.58
Specialty / small-batch
Dec 2025
RIZOCHEM PHARMAC…
Qatar
Capsule
590
$21K
$36.27
Specialty / small-batch
Dec 2025
RIZOCHEM PHARMAC…
Qatar
Capsule
590
$21K
$35.75
Specialty / small-batch
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Emulsion
30
$967.13
$32.24
Specialty / small-batch
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Emulsion
26
$837.71
$32.22
Specialty / small-batch
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Emulsion
26
$837.71
$32.22
Specialty / small-batch
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Emulsion
1
$32.22
$32.22
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
18
$0.404
$0.022
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
18
$0.534
$0.030
Small sample / trial shipment
Dec 2025
BRINTON PHARMACE…
Vanuatu
Capsule
10
$0.356
$0.036
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
units
15
$0.693
$0.046
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
Solution
3
$0.139
$0.046
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
Solution
24
$1.11
$0.046
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
Solution
3
$0.142
$0.047
Small sample / trial shipment
Dec 2025
VAMA HEALTH WORL…
Ghana
Capsule
5
$0.299
$0.060
Small sample / trial shipment
Dec 2025
BRINTON PHARMACE…
Vanuatu
Capsule
25
$1.57
$0.063
Small sample / trial shipment
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Eye Drops
8
$0.557
$0.070
Small sample / trial shipment
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship cyclosporine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYCyclosporine leaves India through 7+ ports. The top 5 (BANGALORE AIR, DELHI AIR, MUMBAI AIR (SAHAR)) handle 99.2% of total USD. AIR moves 97% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 BANGALORE AIR handles $676K — top 7 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYAIR dominates at 97% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$986K
90.3% of USD · 97.2% of ships
SEA
$105K
9.7% of USD · 2.8% of ships
Fig 8.3 The dominant corridor is BANGALORE AIR → Air → N. America ($676K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYZimbabwe is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 3323).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Zimbabwe (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 3,323) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
AVET PHARMACEUTICALS…
United States
ONESOURCE SPECIA…
$676K
4
CRITICAL
CAPITAL PHARMA CARE
Angola
INVEX HEALTH PVT…
$100K
2
MEDIUM
BANCO BOLIVARIANO C.A
Ecuador
PANACEA BIOTEC P…
$63K
1
MEDIUM
INTERNATIONAL TRADIN…
Egypt
RPG LIFE SCIENCE…
$41K
3
MEDIUM
MEDI MYANMAR GROUP LTD
Myanmar
RPG LIFE SCIENCE…
$29K
2
MEDIUM
PASCUAL LABORATORIES…
Philippines
RPG LIFE SCIENCE…
$26K
2
MEDIUM
RIGHT & BRIGHT INTER…
Myanmar
PANACEA BIOTEC P…
$22K
1
MEDIUM
ZAPATERO INTERNATION…
Mauritius
PLEASANT EXPORTS
$6K
5
MEDIUM
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $982K in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST COMPANY
United Arab Emirates
4
$8K
DERRIC WOOD
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Angola
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Ecuador
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Myanmar
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Qatar
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Venezuela
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Egypt
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Mauritius
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nigeria
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Iraq
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Singapore
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Zambia
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Zimbabwe lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (1 suppliers)
This Q
HIGH
A6
Enter Angola (1 suppliers)
This Q
MED
A8
Build Angola distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
1
$676K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
2
Angola
Africa
1
$100K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Ecuador
Other
2
$67K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
4
Myanmar
Asia
2
$50K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
5
Qatar
Other
1
$42K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Venezuela
Other
1
$42K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Egypt
Africa
1
$41K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Philippines
Asia
1
$26K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Mauritius
Africa
2
$8K
+25.9%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Nigeria
Africa
2
$6K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
11
Iraq
Other
1
$4K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Singapore
Asia
3
$4K
0%
LOW
Low competition (3 suppliers), accessible market
13
Zambia
Africa
2
$4K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
14
Sri Lanka
Asia
1
$2K
-66.7%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Hong Kong
Asia
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 212 2025-Q4 Cyclosporine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cyclosporine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 212 2025-Q4 cyclosporine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian cyclosporine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
212
across all regions
TOTAL USD
$1.09M
2025-Q4 FOB value
UNITS
450.2K
tablets, capsules, etc.
SUPPLIERS
41
Indian exporters
BUYERS
30
global importers
COUNTRIES
32
destinations
§10.2 Regional breakdown
Africa
$162K
14.9%
11 ctry · 64 ships
Asia
$142K
13.0%
12 ctry · 128 ships
Europe
$433.93
0.0%
1 ctry · 2 ships
Americas
$786K
72.0%
7 ctry · 15 ships
Oceania
$39.26
0.0%
1 ctry · 3 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $162K (14.9%), spanning 11 countries.
🏢
41 Indian suppliers shipped to 30 buyers across 32 countries — average shipment value $5K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 28 global cyclosporine importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian cyclosporine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
AVET PHARMACEUTICALS INC
United States
4
$676K
ONESOURCE SPECIALTY …
Capsule
2
CAPITAL PHARMA CARE
Angola
2
$100K
INVEX HEALTH PVT LTD
Capsule
3
BANCO BOLIVARIANO C.A
Ecuador
1
$63K
PANACEA BIOTEC PHARM…
Capsule
4
INTERNATIONAL TRADING OFFICE
Egypt
3
$41K
RPG LIFE SCIENCES LTD
Capsule
5
MEDI MYANMAR GROUP LTD
Myanmar
2
$29K
RPG LIFE SCIENCES LTD
Capsule
6
PASCUAL LABORATORIES INC
Philippines
2
$26K
RPG LIFE SCIENCES LTD
Capsule
7
RIGHT & BRIGHT INTERNATIONAL COMPAN
Myanmar
1
$22K
PANACEA BIOTEC PHARM…
Capsule
8
EMIRATES POST COMPANY
United Arab Emirates
81
$8K
DERRIC WOOD
Eye Drops, Ointment, Capsule
9
ZAPATERO INTERNATIONAL LTD
Mauritius
5
$6K
PLEASANT EXPORTS
Eye Drops
10
ZASAN LIFE SCIENCE VENTURES LTD
Nigeria
3
$6K
ZAHIDI PHARMACEUTICA…
Capsule
11
DIFAMEDIC CIA. LTDA
Ecuador
1
$5K
HIRAL LABS LTD
Capsule
12
REGENCY EXIM TRADE LTD
Mauritius
7
$2K
SAVA HEALTHCARE LTD
Eye Drops
13
THE ESSES PHARMACY (PVT) LTD
Sri Lanka
6
$2K
PLEASANT EXPORTS
Capsule, Solution
14
SUCCEED HOLDINGS LTD
Hong Kong
3
$2K
SANITAS MEDTECH INST…
Capsule, Ointment
15
SUCCESS INTER LINK PTE LTD
Singapore
4
$2K
SANITAS MEDTECH INST…
Eye Drops, Capsule
16
ARROW TRADING FZE
United Arab Emirates
1
$564.06
BAKER & DAVIS PVT LTD
Capsule
17
FREIGHTER MADE LOGISTICS LTD
Ghana
4
$493.44
BAKER & DAVIS PVT LTD
Capsule
18
INDIRA GANDHI MEMOROAL HOSPITAL
Maldives
1
$282.45
NU HOSPITALS PVT LTD
Capsule
19
LUSAKA PHARMACEUTICALS LTD
Zambia
1
$264.31
PATSONS INTERNATIONAL
Tablet
20
SALAMA PHARMACUTICALS LTD
Kenya
1
$208.67
M T MADON EXPORTS
Tablet
21
AMDJERAS FIELD HOSPITAL
Chad
1
$121.03
AKASH PHARMA EXPORTS
Ointment
22
AL-NOOR FOR DRUGS & MEDICAL APPLIAN
Yemen
1
$96.49
J.A. UNITED EXPORTS …
Eye Drops
23
NEW SIGHT LTD
Republic of the Congo
1
$70.69
AUROLAB FOUNDATION
Solution
24
RAKAGIY GROUP LTD
Kenya
1
$39.86
M T MADON EXPORTS
Eye Drops
25
THE PHARMACIST
Cayman Islands
2
$34.05
KALINDI OVERSEAS
Eye Drops, Ointment
26
AS PER INVOICE LITHUANIA
Lithuania
1
$18.15
VAMA LIFECARE PVT LTD
Injection
27
EMIRATES POST GROUP
United Arab Emirates
1
$14.32
CLOVERLEAF ECOM PVT …
Drops
28
AS PER INVOICE GHANA
Ghana
4
$3.04
VAMA HEALTH WORLD LLP
Solution, Capsule
This report covers 212 2025-Q4 Cyclosporine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cyclosporine
Talk to our trade analyst
Need a custom cyclosporine report or a deeper dive into any market? Our team is ready.